secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHEMED CORP (CHE)
CIK:        0000019584
Form:       8-K
Filed at:   2025-07-29T23:59:59+00:00
Accession:  0001562762-25-000181
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemed Q2 adjusted EPS $4.27 (-21.9% YoY); cuts FY2025 guidance; VITAS CEO departs
--------------------------------------------------------------------------------

- GAAP EPS $3.57 (-23.2%); adjusted EPS $4.27 (-21.9%); revenue $618.8M (+3.8%).
- VITAS adjusted EBITDA margin ex-Medicare cap 16.2% (-163 bps); Florida cap accrual $16.4M.
- Roto-Rooter adjusted EBITDA margin 21.8% (-517 bps); revenue +0.6% to $222.6M.
- FY2025 adjusted EPS guidance cut to $22.00-$22.30 from $24.95-$25.45; prior year $23.13.
- VITAS CEO Nicholas Westfall resigns eff. July 29, 2025; Joel Wherley named successor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/19584/000156276225000181/0001562762-25-000181-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/19584/000156276225000181/che-20250729x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-25-000181

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer